Drug intelligence / Profile preview

Qushi Yangmo prescription

Development stage: Preclinical
Lead developer: Adiminstraion of traditional Chinese medicine of Zhejiang Province
Administration: Oral

Overview

Qushi Yangmo prescription is a Traditional Chinese Medicine (TCM) herbal formulation composed of ingredients such as Sanchi flower, Ginseng flower, Snow lotus, Daidai flower, and Licorice. It is used to treat intrauterine adhesion (IUA) following hysteroscopic adhesiolysis. The prescription works by hindering fibrosis and promoting the regeneration of endometrial glands, aiming to prevent re-adhesion, improve menstrual flow, and enhance fertility rates. Clinical studies have indicated its therapeutic efficacy in improving outcomes for patients with IUA.

Other names: Yangmo decoction养膜方

Beyond the preview

Go deeper on Qushi Yangmo prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qushi Yangmo prescription.

Explore the full profile